Cargando…
Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
The unprecedented need to acquire a safe and effective vaccine for the long-term control of coronavirus disease 2019 (COVID-19) is a global imperative. Researchers have been working urgently and collaboratively to develop vaccines against the causative agent of COVID-19. The use of messenger RNA (mR...
Autores principales: | Hajissa, Khalid, Mussa, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040488/ https://www.ncbi.nlm.nih.gov/pubmed/33830862 http://dx.doi.org/10.1080/21645515.2021.1900713 |
Ejemplares similares
-
Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines
por: Kelso, John M.
Publicado: (2021) -
The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development
por: Hajissa, Khalid, et al.
Publicado: (2022) -
Diagnosis of Acute Myocarditis Following mRNA Vaccines against SARS-CoV-2: A Methodological Review
por: Zuin, Marco, et al.
Publicado: (2023) -
Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines
por: Gaspar, Emanuelle B., et al.
Publicado: (2021) -
mRNA technology as one of the promising platforms
for the SARS-CoV-2 vaccine development
por: Ilyichev, A.A., et al.
Publicado: (2020)